Sort   by:  
 Page size 
UnknownA phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients.
Not available
S-EPMC4830040 | biostudies-literature
UnknownBortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study.
Not available
S-EPMC7234990 | biostudies-literature
UnknownEfficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study.
Not available
S-EPMC12673357 | biostudies-literature
UnknownRituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi.
Not available
S-EPMC6068040 | biostudies-literature
UnknownIxazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial.
Not available
S-EPMC8651653 | biostudies-literature
UnknownDevelopment and preliminary validation of the Behcet's syndrome Overall Damage Index (BODI).
Not available
S-EPMC7425117 | biostudies-literature
UnknownGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977 | biostudies-literature
UnknownExtended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery: international, prospective, propensity score-weighted cohort study.
Not available
S-EPMC11894929 | biostudies-literature
UnknownSARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.
Not available
S-EPMC7995808 | biostudies-literature
UnknownTiming of surgery following SARS-CoV-2 infection: an international prospective cohort study.
Not available
S-EPMC8206995 | biostudies-literature
Sort   by:  
 Page size